AFM
SMTI icon

Anson Funds Management’s Sanara MedTech SMTI Stock Holding History

Anson Funds Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,097
Closed -$269K – 419
2021
Q4 		$269K Buy
+9,097
New +$286K 0.03% 280

Other funds holding SMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Anson Funds Management's SMTI Position: Q1 2022 in Review

Anson Funds Management sold out of Sanara MedTech (SMTI) in Q1 2022, closing a stake of 9,097 shares — an estimated $269K sold.

Anson Funds Management first reported a position in SMTI in Q4 2021 and held it in 1 quarter. The position peaked at $269K in Q4 2021. 21 funds tracked by Wall St. Rank hold SMTI as of Q1 2022.

  • Anson Funds Management reported no remaining Sanara MedTech position as of Q1 2022 after selling out during the quarter.
  • Anson Funds Management sold 9,097 Sanara MedTech shares in Q1 2022, an estimated $269K.
  • Anson Funds Management first reported a position in Sanara MedTech in Q4 2021 and held it in 1 quarter.
  • Anson Funds Management's Sanara MedTech position peaked at $269K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2022.

Based on Anson Funds Management's 13F filing for Q1 2022, filed 12 May 2022.